Abstract
Mei-Xuan Shao, Yun Niu, Zhen-Long Zhao, Ming-An Yu
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
A population-based study of the three major variants of papillary thyroid carcinoma
10.1177/0300060520984618 · 2021
Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study
10.1002/cncr.21653 · 2006
Skip metastasis in papillary thyroid carcinoma is difficult to predict in clinical practice
10.1186/s12885-017-3698-2 · 2017
Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer
10.1016/s0039-6060(03)00424-0 · 2003
2024 international expert consensus on US-guided thermal ablation for T1N0M0 papillary thyroid cancer
10.1148/radiol.240347 · 2025
A clinical study of microwave ablation for cervical lymph node metastasis from papillary thyroid cancer
10.3389/fendo.2025.1580765 · 2025
Ablation techniques in non-small cell lung cancer patients: experience of a single center
2022
Thermal ablation in non-small cell lung cancer: a review of treatment modalities and the evidence for combination with immune checkpoint inhibitors
10.21037/tlcr-20-1075 · 2021
A preliminary comparative study of microwave ablation for cervical lymph node metastases originating from papillary thyroid carcinoma vs. non-papillary thyroid carcinoma
10.1080/02656736.2025.2553205 · 2025
The value of Ki-67 labeling index in central lymph node metastasis and survival of papillary thyroid carcinoma: evidence from the clinical and molecular analyses
10.1177/10732748231155701 · 2023
Kank1 and Ki67 expression are associated with poor prognosis in human pulmonary adenocarcinoma
2020
Tumor cell proliferation (Ki-67) expression and its prognostic significance in histological subtypes of lung adenocarcinoma
10.1016/j.lungcan.2021.02.009 · 2021
Comparison of proliferating cell nuclear antigen, thyroid transcription factor-1, Ki-67, p63, p53 and high-molecular weight cytokeratin expressions in papillary thyroid carcinoma, follicular carcinoma, and follicular adenoma
10.1016/j.anndiagpath.2010.11.005 · 2011
Anaplastic transformation of papillary thyroid carcinoma in recurrent disease in regional lymph nodes: a histologic and immunohistochemical study
10.1002/(sici)1096-9098(199901)70:1<45::aid-jso8>3.0.co;2-b · 1999
Utility of BRAF protein overexpression in predicting the metastasis potential of papillary thyroid carcinoma
10.3892/ol.2010.219 · 2011
Clinical significance of p53 protein expression in papillary thyroid carcinoma
10.1007/s00268-008-9756-9 · 2008
Prognostic impact of TP53 mutations in metastatic nonsquamous non-small-cell lung cancer
10.1016/j.cllc.2023.12.004 · 2024
TP53 mutation is associated with a poor clinical outcome for non-small cell lung cancer: evidence from a meta-analysis
10.3892/mco.2016.1057 · 2016
MMP-9-1562 C/T single nucleotide polymorphism associates with increased MMP-9 level and activity during papillary thyroid carcinoma progression
10.1016/j.pathol.2018.10.008 · 2019
Inhibition of metalloproteinases-2, -9, and -14 suppresses papillary thyroid carcinoma cell migration and invasion
10.3390/ijms26167956 · 2025
Correlation between matrix metalloproteinase-9 and vascular endothelial growth factor expression in lung adenocarcinoma
10.4238/2015.december.29.44 · 2015
No additional external references are available.